Compounds > lopinavir
Page last updated: 2024-08-26

lopinavir and Cancer of Cervix

lopinavir has been researched along with Cancer of Cervix in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anastos, K; Burk, RD; Dugan, KB; DʼSouza, G; Eltoum, IE; Flowers, L; Lahiri, CD; Massad, LS; Ofotokun, I; Palefsky, JM; Rahangdale, L; Reimers, L; Strickler, HD; Xie, X; Xue, X1
Allwood, JW; Goodacre, R; Hampson, IN; Hampson, L; Jarvis, RM; Kim, DH; Oliver, AW; Xu, Y1
Allwood, JW; Batman, G; Goodacre, R; Hampson, IN; Hampson, L; Jarvis, RM; Kim, DH; Marsden-Edwards, E; Moore, RE1
Batman, G; Hampson, IN; Hampson, L; Oliver, AW; Richard, C; Zehbe, I1
Hampson, IN; Hampson, L; Kitchener, HC1

Other Studies

5 other study(ies) available for lopinavir and Cancer of Cervix

ArticleYear
Oral Lopinavir Use and Human Papillomavirus Infection in HIV-Positive Women.
    Journal of acquired immune deficiency syndromes (1999), 2015, Oct-01, Volume: 70, Issue:2

    Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Lopinavir; Papillomaviridae; Papillomavirus Infections; Uterine Cervical Neoplasms

2015
Combining metabolic fingerprinting and footprinting to understand the phenotypic response of HPV16 E6 expressing cervical carcinoma cells exposed to the HIV anti-viral drug lopinavir.
    The Analyst, 2010, Volume: 135, Issue:6

    Topics: Anti-HIV Agents; Carcinoma; Cell Line, Tumor; Female; Humans; Lopinavir; Metabolomics; Oncogene Proteins, Viral; Phenotype; Principal Component Analysis; Pyrimidinones; Repressor Proteins; Spectroscopy, Fourier Transform Infrared; Uterine Cervical Neoplasms

2010
Raman chemical mapping reveals site of action of HIV protease inhibitors in HPV16 E6 expressing cervical carcinoma cells.
    Analytical and bioanalytical chemistry, 2010, Volume: 398, Issue:7-8

    Topics: Cell Fractionation; Cell Line, Tumor; Chromatography, Liquid; Female; HIV Protease Inhibitors; Human papillomavirus 16; Humans; Indinavir; Lopinavir; Oncogene Proteins, Viral; Papillomavirus Infections; Principal Component Analysis; Pyrimidinones; Repressor Proteins; Spectrometry, Mass, Electrospray Ionization; Spectrum Analysis, Raman; Transfection; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms

2010
Lopinavir up-regulates expression of the antiviral protein ribonuclease L in human papillomavirus-positive cervical carcinoma cells.
    Antiviral therapy, 2011, Volume: 16, Issue:4

    Topics: Antiviral Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Endoribonucleases; Female; HIV Protease Inhibitors; Human papillomavirus 16; Humans; Lopinavir; Papillomavirus Infections; Pyrimidinones; Up-Regulation; Uterine Cervical Neoplasms

2011
Specific HIV protease inhibitors inhibit the ability of HPV16 E6 to degrade p53 and selectively kill E6-dependent cervical carcinoma cells in vitro.
    Antiviral therapy, 2006, Volume: 11, Issue:6

    Topics: Animals; Carcinoma; Cell Line, Tumor; Female; HIV Protease Inhibitors; Humans; Lopinavir; Mice; NIH 3T3 Cells; Oncogene Proteins, Viral; Proteasome Endopeptidase Complex; Pyrimidinones; Repressor Proteins; Transfection; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms

2006